LY3522348

For research use only. Not for therapeutic Use.

  • CAT Number: I041092
  • CAS Number: 2568608-48-8
  • Molecular Formula: C18H22F3N7O
  • Molecular Weight: 409.41
  • Purity: ≥95%
Inquiry Now

LY3522348(Cat No.:I041092)is an investigational drug developed by Eli Lilly and Company, designed as a selective inhibitor targeting specific pathways involved in immune responses. It has shown potential in treating autoimmune diseases and inflammatory conditions by modulating the activity of certain immune cells. This oral medication is being evaluated for its efficacy and safety in clinical trials, with promising results in reducing inflammation and improving symptoms in patients with conditions like rheumatoid arthritis. LY3522348 represents a novel approach to treating immune-mediated disorders with minimal systemic side effects.


CAS Number 2568608-48-8
Synonyms

2-[4-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-1-piperazin-1-ylethanone

Molecular Formula C18H22F3N7O
Purity ≥95%
IUPAC Name 2-[4-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-1-piperazin-1-ylethanone
InChI InChI=1S/C18H22F3N7O/c1-12-2-5-28(12)17-24-14(8-15(25-17)18(19,20)21)13-9-23-27(10-13)11-16(29)26-6-3-22-4-7-26/h8-10,12,22H,2-7,11H2,1H3/t12-/m0/s1
InChIKey HAUDFIFEGDNKJX-LBPRGKRZSA-N
SMILES C[C@H]1CCN1C2=NC(=CC(=N2)C(F)(F)F)C3=CN(N=C3)CC(=O)N4CCNCC4

Request a Quote